Featured
Vaccines: Death toll increases after AZ shots; agency widens investigation
South Korea is investigating three more deaths following inoculation with AstraZeneca’s Coronavirus (COVID-19) vaccine, the Korea Agency for Disease Control and Prevention (KDCA) said on Thursday.
This is in addition to the two fatalities reported earlier in the week.On Wednesday, the Yonhap news agency reported that two South Korean citizens, who had multiple underlying diseases, died after receiving AstraZeneca’s coronavirus vaccine.
The first person, in their 50s, died the day after receiving the vaccine after showing symptoms of heart failure.
The second person — a 63-year-old man with cerebrovascular disease — also died on Wednesday morning, four days after receiving the injection.According to the KDCA, among the three people who died, two were men in their 50s from nursing homes.
One man died 41 hours after the injection, while the other after 15 hours.
The third was a young woman in her 20s, who was receiving treatment at a care facility for disabled persons and died 15 hours after receiving the shot.Health officials are currently investigating whether the deaths were caused by side effects from the vaccine.
South Korea uses the AstraZeneca vaccine for medical staff and patients in nursing homes but has banned it for senior citizens aged 65 and older, as data on the vaccine’s effects on the elderly is insufficient.
Continue Reading
-
Football1 week agoArsenal confirm departure of 15 players ahead of summer exit
-
Crime7 days agoLASU student dies after armed robbery attack
-
Featured7 days agoOsun APC counters Adeleke over security drone dispute, urges public to ignore allegations against Oyetola
-
Politics7 days agoEmeka Ike reacts to alleged INEC-linked data breach
-
Politics7 days agoFour PDP reps from Bauchi defect to APM, cite internal party crisis
-
News1 week agoCelebrating Governor Mutfwang’s visionary leadership three years on
-
Latest5 days agoAkpabio denies promising APC tickets to defeated Senators
-
Latest1 week agoJonathan’s silence fuels speculation over 2027 presidency ambition